Catherine Franklin

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Samuel Lederman, Faith D Ottery, Antonio Cano et al. · The Lancet · 2023 · 244 citations

Pharmacy, Gynecology, Pharmacotherapy +11

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Kimball A. Johnson, Nancy Martin, Rossella E. Nappi et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 193 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +13

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause

Genevieve Neal-Perry, Antonio Cano, Samuel Lederman et al. · Obstetrics and Gynecology · 2023 · 110 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Unexplained regression in Down syndrome: Management of 51 patients in an international patient database

Stephanie L. Santoro, Nicole Baumer, Michelle Cornacchia et al. · American Journal of Medical Genetics Part A · 2022 · 40 citations

Medicine, Pediatrics, Pharmacotherapy +13

Management Guidelines: developmental disability

Nicholas Lennox, H. Boocock, Carol Bower et al. · UWA Profiles and Research Repository (University of Western Australia) · 2012 · 29 citations

Medicine, Human Development, Pediatrics +14